课题基金 / 基金详情

Clarification of pathogenesis and development of therapeutic strategy for small-for size syndrome after major hepatectomy in biliary tract cancer

Clarification of pathogenesis and development of therapeutic strategy for small-for size syndrome after major hepatectomy in biliary tract cancer
胆道癌肝大部切除术后小体积综合征发病机制的阐明及治疗策略的制定
批准号:
17390361
负责人:
MIYAZAKI Masaru
金额:
$10.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

MIYAZAKI Masaru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
(1)Clinical StudyPostoperative hepatic insufficiency is a critical complication after extended hepatic resection in patients with biliary tract malignancies, the majority of whom suffer from obstructive jaundice. The aim of this study was to assess clinical parameters linked to this type of liver dysfunction.Methods : A total of 111 patients were retrospectively reviewed. Patient background, pre- and intra-operative parameters, and a ratio of remnant liver volume/entire liver volume (RLV/ELV) as a volumetric parameter, were compared between patients with and without postoperative hyperbilirubinemia and subsequent fatal outcome.Results : Logistic regression indicated that only RLV/ELV ratio was an independent factor influencing postoperative hyperbilirubinemia, and RLV/ELV ratio and indocyanine green retention rate at 15 minutes (ICG-R15) were factors affecting survival. Patients with RLV/ELV<40% had 7.6 times the risk of postoperative hyperbilirubinemia, while no patients having RLV/EL … More V>40% and ICG-R15<25% died of liver failure.Conclusions : The RLV/ELV ratio was the factor with the greatest impact on liver dysfunction after extended hepatic resection in patients with biliary tract malignancies. To prevent these morbidities, volumetric analysis should be performed in a prospective fashion, and, when necessary, preoperative portal vein embolization, or, if possible, limited hepatic resection should be applied.(2)Experimental StudyThe effects of obstructive jaundice on liver regeneration after partial hepatectomy are not yet fully understood.Methods : Hepatocyte growth factor (HGF), its receptor, c-Met, vascular endothelial growth factor (VEGF) and transforming growth factor-f31 (TGF-β1) mRNA expression in both liver tissue and isolated liver cells were investigated after biliary obstruction (BO) by quantitative reverse-transcription polymerase chain reaction (RT-PCR) using a LightCycler. Immunohistochemical staining for desmin and α-smooth muscle actin (α-SMA) was also studied. Regenerating liver weight and proliferating cell nuclear antigen (PCNA) labeling index, and growth factor expression were then evaluated after 70% hepatectomy with concomitant internal biliary drainage in BO rats or sham-operated rats.Results : Hepatic TGF-β1 mRNA levels increased significantly 14 days after BO, and further increased with length of cholestasis. Meanwhile, HGF and VEGF tended to increase, but was not significant. In cell isolates, TGF-β1 mRNA was found mainly in the hepatic stellate cell (HSC) fraction. Immunohistochemical studies revealed increased number of HSCs (desmin-positive cells) and activated HSCs (α-SMA-positive cells) in portal areas after BO. In a hepatectomy model, liver regeneration was delayed in BO rats, as compared to sham-operated rats. TGF-β1 mRNA was significantly up-regulated up to 48h after hepatectomy, and the earlier HGF mRNA peak was lost in BO rats.Conclusion : BO induces HSCs proliferation and activation, leading to up-regulation of TGF-β1 mRNA and suppression of HGF mRNA in livers. These altered expression patterns may be strongly involved in delayed liver regeneration after hepatectomy with obstructive jaundice. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.amjsurg.2005.01.010
发表时间: 2005-04-01
期刊: AMERICAN JOURNAL OF SURGERY
影响因子: 3
作者: [Yoshidome, H, Takeuchi, D, Miyazaki, M]
通讯作者: Miyazaki, M
Decreased cell-mediated Immune status in colorectal cancer patients with hepatic metastasis
结直肠癌肝转移患者细胞介导的免疫状态下降
DOI: --
发表时间: 2005
期刊: Hepato-Gastroenterology 52
影响因子: --
作者: [清水 宏明, 他]
通讯作者:
胆嚢癌手術における拡大肝切除とその適応
扩大肝切除及其在胆囊癌手术中的适应证
DOI: --
发表时间: 2005
期刊: 消化器外科 28
影响因子: --
作者: [宮崎 勝, 他]
通讯作者:
DOI: 10.3748/wjg.v12.i13.2053
发表时间: 2006-04-07
期刊: WORLD JOURNAL OF GASTROENTEROLOGY
影响因子: 4.3
作者: [Makino, Hironobu, Shimizu, Hiroaki, Miyazaki, Masaru]
通讯作者: Miyazaki, Masaru
10
    Molecular mechanisms of tumorigenesis of enteric and pancreatic neuroendocrine tumor and development of new molecular targeting therapy.
    • 批准号:
      23659638
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      MIYAZAKI Masaru
    • 依托单位:
    Increased circulating cell signaling phosphoproteins in sera are useful for early detection and the tailor-made therapy for pancreatic and biliary duct cancer patients.
    • 批准号:
      21390372
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.56万
    • 财政年份:
      2009
    • 负责人:
      MIYAZAKI Masaru
    • 依托单位:
    Mechanism of Liver Organogenesis and Its Application to Liver
    • 批准号:
      14370376
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2002
    • 负责人:
      MIYAZAKI Masaru
    • 依托单位:
    Expression of Somatostatin-Receptor and Inhibitory Effect of Somatostatin on Cell Proliferation in Hepatobiliary Malignancies
    • 批准号:
      10671156
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      1998
    • 负责人:
      MIYAZAKI Masaru
    • 依托单位:
    海外基金